{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:27:17Z","timestamp":1793618837688,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"US Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["75N910D00024"],"award-info":[{"award-number":["75N910D00024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ebiom.2026.106515","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:21:40Z","timestamp":1792153300000},"page":"106515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early detection of immunoglobulin A against a vaccine backbone protein enables fast, durable, and objective identification of individuals vaccinated against Ebola virus"],"prefix":"10.1016","volume":"133","author":[{"given":"Olivia","family":"Posadas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina Maljkovic","family":"Berry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviane","family":"Callier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Kieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier Tshiani","family":"Mbaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystle","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa E.","family":"Hensley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7800-6045","authenticated-orcid":false,"given":"Jens H.","family":"Kuhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Crozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard T.","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Clifford","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Follmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0593-7965","authenticated-orcid":false,"given":"Surender","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ebiom.2026.106515_bib1","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001955","article-title":"ICTV virus taxonomy profile: Filoviridae 2024","volume":"105","author":"Biedenkopf","year":"2024","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ebiom.2026.106515_bib2","series-title":"Harrison's Principles of Internal Medicine","first-page":"1679","article-title":"Filovirids: orthoebolavirus and orthomarburgvirus infections","author":"Kuhn","year":"2026"},{"issue":"10068","key":"10.1016\/j.ebiom.2026.106515_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106515_bib4","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa1904387","article-title":"Ebola outbreak response in the DRC with rVSV-ZEBOV-GP ring vaccination","volume":"391","author":"Muyembe","year":"2024","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106515_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002600","article-title":"Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus","volume":"7","author":"Mire","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106515_bib7","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cell.2018.07.033","article-title":"Systematic analysis of monoclonal antibodies against Ebola virus GP defines features that contribute to protection","volume":"174","author":"Saphire","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106515_bib8","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3390\/pathogens11030374","article-title":"Development and structural analysis of antibody therapeutics for filoviruses","volume":"11","author":"Yu","year":"2022","journal-title":"Pathogens"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106515_bib9","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/vaccines9030190","article-title":"Development of pandemic vaccines: ERVEBO case study","volume":"9","author":"Wolf","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106515_bib10","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106515_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101699","article-title":"Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: results from the EVISTA cohort in the Democratic Republic of the Congo","volume":"54","author":"Jaspard","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106515_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S1473-3099(23)00819-8","article-title":"Case fatality risk among individuals vaccinated with rVSV\u0394G-ZEBOV-GP: a retrospective cohort analysis of patients with confirmed Ebola virus disease in the Democratic Republic of the Congo","volume":"24","author":"Coulborn","year":"2024","journal-title":"Lancet Infect Dis"},{"issue":"13","key":"10.1016\/j.ebiom.2026.106515_bib13","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa2024670","article-title":"Ebola virus transmission initiated by relapse of systemic Ebola virus disease","volume":"384","author":"Mbala-Kingebeni","year":"2021","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106515_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S2666-5247(24)00163-0","article-title":"Safety and immunogenicity of a delayed booster dose of the rVSVDeltaG-ZEBOV-GP vaccine for prevention of Ebola virus disease: a multicentre, open-label, phase 2 randomised controlled trial","volume":"5","author":"Davey","year":"2024","journal-title":"Lancet Microbe"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106515_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/s41590-026-02459-w","article-title":"Improved VSV-Ebola-GP booster vaccination approach promotes antibody affinity maturation and durable anti-Ebola immunity in humans","volume":"27","author":"Khurana","year":"2026","journal-title":"Nat Immunol"},{"issue":"14","key":"10.1016\/j.ebiom.2026.106515_bib16","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/j.vaccine.2020.02.044","article-title":"Prior vaccination with recombinant Vesicular Stomatitis Virus\u2013Zaire Ebolavirus vaccine is associated with improved survival among patients with Ebolavirus infection","volume":"38","author":"Kasereka","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ebiom.2026.106515_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijid.2021.09.053","article-title":"Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program","volume":"113","author":"Jaspard","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106515_bib18","doi-asserted-by":"crossref","first-page":"e1730","DOI":"10.1016\/S2214-109X(24)00255-9","article-title":"Improving Ebola virus disease outbreak control through targeted post-exposure prophylaxis","volume":"12","author":"Hoffmann Dahl","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ebiom.2026.106515_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104186","article-title":"Ebola-detect: a differential serodiagnostic assay for Ebola virus infections and surveillance in the presence of vaccine-induced antibodies","volume":"82","author":"Ravichandran","year":"2022","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106515_bib20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3201\/eid3204.251906","article-title":"Confirming ERVEBO vaccination to support Ebola virus surveillance","volume":"32","author":"Karaaslan","year":"2026","journal-title":"Emerg Infect Dis"},{"issue":"15","key":"10.1016\/j.ebiom.2026.106515_bib21","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1614067","article-title":"Phase 2 placebo-controlled trial of two vaccines to prevent Ebola in Liberia","volume":"377","author":"Kennedy","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106515_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215457","article-title":"Development, qualification, and validation of the Filovirus Animal Nonclinical Group anti-ebola virus glycoprotein immunoglobulin G enzyme-linked immunosorbent assay for human serum samples","volume":"14","author":"Rudge","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106515_bib23","doi-asserted-by":"crossref","first-page":"8133","DOI":"10.1038\/s41467-024-51021-5","article-title":"Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design","volume":"15","author":"Khurana","year":"2024","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106515_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1414216","article-title":"A recombinant vesicular stomatitis virus Ebola vaccine","volume":"376","author":"Regules","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106515_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/infdis\/jiy565","article-title":"Detectable vesicular stomatitis virus (VSV)-specific humoral and cellular immune responses following VSV-Ebola virus vaccination in humans","volume":"219","author":"Poetsch","year":"2019","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106515_bib26","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.vaccine.2023.01.059","article-title":"Cellular and humoral immunity to Ebola Zaire glycoprotein and viral vector proteins following immunization with recombinant vesicular stomatitis virus-based Ebola vaccine (rVSV\u0394G-ZEBOV-GP)","volume":"41","author":"Raabe","year":"2023","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106515_bib27","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/infdis\/jiae632","article-title":"Vector-induced humoral responses after rVSVDeltaG-ZEBOV-GP immunization identify vaccinated individuals and correlate with Ebola virus glycoprotein antibodies","volume":"232","author":"Chandrasekaran","year":"2025","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106515_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106515_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-19095-7","article-title":"Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders","volume":"12","author":"Montague","year":"2022","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106515_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0249499","article-title":"Human IgG and IgA responses to COVID-19 mRNA vaccines","volume":"16","author":"Wisnewski","year":"2021","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106515_bib31","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/nm.4201","article-title":"Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies","volume":"22","author":"Khurana","year":"2016","journal-title":"Nat Med"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106515_bib32","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/j.celrep.2017.08.023","article-title":"Systems vaccinology identifies an early innate immune signature as a correlate of antibody responses to the Ebola vaccine rVSV-ZEBOV","volume":"20","author":"Rechtien","year":"2017","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106515_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007654","article-title":"Serological analysis of Ebola virus survivors and close contacts in Sierra Leone: a cross-sectional study","volume":"13","author":"Halfmann","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106515_bib34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/CMR.00003-16","article-title":"Diagnosis of Ebola virus disease: past, present, and future","volume":"29","author":"Broadhurst","year":"2016","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106515_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1146\/annurev-virology-110615-040056","article-title":"Epidemiology and management of the 2013\u201316 West African Ebola outbreak","volume":"3","author":"Boisen","year":"2016","journal-title":"Annu Rev Virol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106515_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101244","article-title":"Fast-acting single-dose vesicular stomatitis virus-Sudan virus vaccine: a challenge study in macaques","volume":"6","author":"Fletcher","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.ebiom.2026.106515_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101110","article-title":"Uganda launches vaccine trial for Sudan virus disease","author":"Adepoju","year":"2025","journal-title":"Lancet Microbe"},{"issue":"Suppl 7","key":"10.1016\/j.ebiom.2026.106515_bib38","doi-asserted-by":"crossref","first-page":"S712","DOI":"10.1093\/infdis\/jiad207","article-title":"A recombinant vesicular stomatitis virus-based vaccine provides postexposure protection against Bundibugyo ebolavirus infection","volume":"228","author":"Woolsey","year":"2023","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.ebiom.2026.106515_bib39","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJMoa2501073","article-title":"Safety and immunogenicity of an rVSV Lassa fever vaccine candidate","volume":"393","author":"Malkin","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106515_bib40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/JCM.01979-16","article-title":"Development of a sensitive and specific serological assay based on Luminex technology for detection of antibodies to Zaire Ebola virus","volume":"55","author":"Ayouba","year":"2017","journal-title":"J Clin Microbiol"},{"issue":"10174","key":"10.1016\/j.ebiom.2026.106515_bib41","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(18)33132-5","article-title":"Ebola virus disease","volume":"393","author":"Malvy","year":"2019","journal-title":"Lancet"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426003993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T10:49:30Z","timestamp":1793616570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426003993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":40,"alternative-id":["S2352396426003993"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106515","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early detection of immunoglobulin A against a vaccine backbone protein enables fast, durable, and objective identification of individuals vaccinated against Ebola virus","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106515"}}